Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1228 ARTÍCULOS , VIENDO DEL 721 AL 735

Cognitive Decline in Preclinical Stage 2 Alzheimer Disease and Implications for Prevention Trials

Mormino EC, Papp KV.

JAMA Neurol. 2016 Jun 1;73(6):640-2. doi: 10.1001/jamaneurol.2016.0281.

Common variant in PTK2B is associated with late-onset Alzheimer's disease: A replication study and meta-analyses

Li YQ, Tan MS, Wang HF, Tan CC, Zhang W, Zheng ZJ, Kong LL, Wang ZX, Tan L, Jiang T, Tan L, Yu JT.

Neurosci Lett. 2016 May 16;621:83-87. doi: 10.1016/j.neulet.2016.04.020. Epub 2016 Apr 11.

Meta-analysis of Telomere Length in Alzheimer's Disease

Forero DA, González-Giraldo Y, López-Quintero C, Castro-Vega LJ, Barreto GE, Perry G.

J Gerontol A Biol Sci Med Sci. 2016 Aug;71(8):1069-73. doi: 10.1093/gerona/glw053. Epub 2016 Apr 18.

Poor self-rated health did not increase risk of permanent nursing placement or mortality in people with mild Alzheimer's disease

Nielsen AB, Siersma V, Waldemar G, Waldorff FB.

BMC Geriatr. 2016 Apr 19;16:87. doi: 10.1186/s12877-016-0262-x.

Disentangling the Treatment of Agitation in Alzheimer's Disease

Howard RJ.

Am J Psychiatry. 2016 May 1;173(5):441-3. doi: 10.1176/appi.ajp.2016.16010083.

Pharmacological Management of Agitation and Aggression in Alzheimer's Disease: A Review of Current and Novel Treatments

Liu CS, Ruthirakuhan M, Chau SA, Herrmann N, Carvalho AF, Lanctôt KL.

Curr Alzheimer Res. 2016;13(10):1134-44. doi: 10.2174/1567205013666160502122933.

NME8 rs2718058 polymorphism with Alzheimer's disease risk: a replication and meta-analysis

Liu SL, Wang XC, Tan MS, Wang HF, Zhang W, Wang ZX, Yu JT, Tan L.

Oncotarget. 2016 Jun 14;7(24):36014-36020. doi: 10.18632/oncotarget.9086.

A Systematic Review and Meta-Analysis of On-Road Simulator and Cognitive Driving Assessment in Alzheimer's Disease and Mild Cognitive Impairment

Hird MA, Egeto P, Fischer CE, Naglie G, Schweizer TA.

J Alzheimers Dis. 2016 May 11;53(2):713-29. doi: 10.3233/JAD-160276.

Impact of SORL1 genetic variations on MRI markers in non-demented elders

Yin RH, Li J, Tan L, Wang HF, Tan MS, Yu WJ, Tan CC, Yu JT, Tan L; Alzheimer’s Disease Neuroimaging Initiative.

Oncotarget. 2016 May 31;7(22):31689-98. doi: 10.18632/oncotarget.9300.

Disrupted Network Topology in Patients with Stable and Progressive Mild Cognitive Impairment and Alzheimer's Disease

Pereira JB, Mijalkov M, Kakaei E, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, Spenger C, Lovestone S, Simmons A, Wahlund LO, Volpe G, Westman E.

Cereb Cortex. 2016 Aug;26(8):3476-3493. doi: 10.1093/cercor/bhw128. Epub 2016 May 13.

Adrenergic Drugs Blockers or Enhancers for Cognitive Decline ? What to Choose for Alzheimer's Disease Patients?

Femminella GD, Leosco D, Ferrara N, Rengo G.

CNS Neurol Disord Drug Targets. 2016;15(6):665-71. doi: 10.2174/1871527315666160518123201.

Non-Demented Individuals with Alzheimer's Disease Neuropathology: Resistance to Cognitive Decline May Reveal New Treatment Strategies

Zolochevska O, Taglialatela G.

Curr Pharm Des. 2016;22(26):4063-8. doi: 10.2174/1381612822666160518142110.

Influence of four polymorphisms in ABCA1 and PTGS2 genes on risk of Alzheimer's disease: a meta-analysis

Chen Q, Liang B, Wang Z, Cheng X, Huang Y, Liu Y, Huang Z.

Neurol Sci. 2016 Aug;37(8):1209-20. doi: 10.1007/s10072-016-2579-9. Epub 2016 May 23.

New data on harmful effects of trans-fatty acids

Ginter E, Simko V.

Bratisl Lek Listy. 2016;117(5):251-3. doi: 10.4149/bll_2016_048.

Cognitive impairment

Muayqil T.

Neurosciences (Riyadh). 2016 Jan;21(1):81-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias